Open Alveolar Soft Part Sarcoma Clinical Trials Summer 2026
Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced
Yosef
July 18, 2026
Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced
A peer-reviewed study published in Nature Cancer describes GCAR1, an experimental CAR T-cell therapy that
On December 9, 2022, the Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.)
Dear ASPS community, please read the recent update of this clinical trial from September 2020:
The American Society of Clinical Oncology (ASCO) annual meeting took place this year in Chicago
Below are summaries of three clinical studies and one preclinical study on Alveolar Soft Part
OPEN NOW: ​​​APROMISS – A Phase III Study of AL3818 (Anlotinib) Hydrochloride Monotherapy in Subjects
A presentation is the recent annual meeting of the American Society of Clinical Oncology (ASCO)
New clinical trial for ASPS is expected to open on March 2016. Study number: NCT02636725
OPEN NOW: CASPS – A Phase II Trial of Cediranib in the Treatment of Patients